Resmetirom
MGL-3196-19
Phase 3 small_molecule active
Quick answer
Resmetirom for NASH is a Phase 3 program (small_molecule) at MADRIGAL PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MADRIGAL PHARMACEUTICALS, INC.
- Indication
- NASH
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active